What is Zacks Research’s Estimate for JAZZ Q2 Earnings?
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities research analysts at Zacks Research issued their Q2 2025 EPS estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Tuesday, May 27th. Zacks Research analyst S. Ganoria expects that the specialty pharmaceutical company will post earnings of ($8.76) per share for […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) – Equities research analysts at Zacks Research issued their Q2 2025 EPS estimates for shares of Jazz Pharmaceuticals in a research note issued to investors on Tuesday, May 27th. Zacks Research analyst S. Ganoria expects that the specialty pharmaceutical company will post earnings of ($8.76) per share for […]
